Generex Biotechnology Corporation (GNBT) looks positive for gain today!

"WORCESTER, Mass. and MUMBAI, India, Nov 14, 2008 (GlobeNewswire via COMTEX) -- ( :: Generex Biotechnology Corporation ::), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, and Shreya Life Sciences Pvt. Ltd. ( www.shreya.co.in), the Company's importation, marketing and distribution licensee in India and the fourth largest marketer of insulin in India, jointly announced today the launch of commercial retail sales of Generex Oral-lyn(tm) in India. Generex Oral-lyn is approved in India for the treatment of adults and children with Type 1 and Type 2 diabetes and will be marketed and sold in India under the brand name "Oral-Recosulin"."